<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00581282</url>
  </required_header>
  <id_info>
    <org_study_id>HS#2004-4019</org_study_id>
    <nct_id>NCT00581282</nct_id>
  </id_info>
  <brief_title>Brain Imaging Studies of the Effects of Cocaine Abstinence</brief_title>
  <official_title>Brain Imaging Studies of the Effects of Cocaine Abstinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates theories regarding cocaine abstinence which propose that increased
      presynaptic and postsynaptic dopamine activity and increased serotonin activity are
      associated with abstinence in cocaine dependent subjects at the beginning and three to six
      months after a treatment program. We are using positron emission tomography (PET), Magnetic
      Resonance Imaging (MRI) and diffusion tensor imaging (DTI) in cortical and subcortical areas
      in a series of brain imaging studies testing these theories of abnormalities in the dopamine
      and serotonin system for cocaine addiction by examining the distribution of 18F-fallypride,
      18F-altanserin, and FDG. We are evaluating genetic theories associated with cocaine addiction
      through the examination of genetic markers and functional genomics.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2006</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>PET scans, fMRI scans</measure>
    <time_frame>The beginning and three to six months after a treatment program</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Substance Abuse Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Cocaine abstinent group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Normal healthy control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>PET scan</intervention_name>
    <description>positron emission tomography PET scan</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>functional magnetic resonance imaging fMRI</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants in cocaine dependency treatment program Normal Healthy Control Subjects
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Inclusion criteria include:

          1. Subjects must be male or female and English speaking.

          2. Subjects must be adults with a history of diagnosis of cocaine dependence disorder
             (n=20) who are under supervised treatment for dependence or normal control (n=10).

          3. Subjects must be between 21 to 65 years of age.

        Exclusion Criteria:

        Exclusion criteria include:

          1. Suicidality or psychosis.

          2. Head injury, kidney or bladder disease or any unstable or serious medical conditions.

          3. Prior exposure to radiation (including diagnostic or treatment x-rays), which might
             cause subjects to exceed standard guidelines.

          4. Unwillingness or inability to adhere to the requirements of the study.

          5. Donation or large loss of blood (&gt;400 ml) within the past month.

          6. Current or very recent illnesses, painful conditions or other disorders, which in the
             judgment of the investigators, might invalidate the scientific goals of the study or
             pose undesirable difficulties or risks for subjects.

          7. Pregnancy or breast feeding.

          8. Individuals who would be unable to undergo a magnetic resonance imaging (MRI) scan,
             for example, individuals who suffer from claustrophobia, or who have metal clips in
             their body, metallic prostheses (i.e., replacement body parts, such as a hip joint), a
             pacemaker, or other pieces of metal in their body (shrapnel, metal filings, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph C Wu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joseph C Wu, M.D.</last_name>
    <phone>949-824-7867</phone>
    <email>jcwu@uci.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, Irvine, Brain Imaging Center</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph C Wu, M.D.</last_name>
      <phone>949-824-7867</phone>
      <email>jcwu@uci.edu</email>
    </contact>
    <investigator>
      <last_name>Mark L Katz, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Potkin, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jogesh Mukherjee, Ph.D., CV</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Orhan Nalcioglu, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tugan Muftuler, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marquis Vawter, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Rodriguez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nikunj Shah, B.A.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Keator</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carol Schachat, M.A.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2007</study_first_posted>
  <last_update_submitted>October 14, 2010</last_update_submitted>
  <last_update_submitted_qc>October 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Joseph C. Wu, M. D. ,Associate Professor, Psychiatry, UCI-SOM, Clinical Director, Brain Imaging Center</name_title>
    <organization>University of California, Irvine</organization>
  </responsible_party>
  <keyword>Cocaine abstinence</keyword>
  <keyword>PET scan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

